1. James G. Fujimoto

    0 Comments Leave a Comment

    1-15 of 319 1 2 3 4 ... 20 21 22 »
    1. Mentioned In 319 Articles

    2. Study shows new technology may improve management of leading causes of blindness

      Study shows new technology may improve management of leading causes of blindness
      ...gnition Lab and School of Advanced Optical Technologies (SAOT) at University Erlangen-Nuremberg, Germany, and James G. Fujimoto, PhD with the Department of Electrical Engineering & Computer Science and Research Laborator...
      Read Full Article
    3. Postprocessing algorithms to minimize fixed-pattern artifact and reduce trigger jitter in swept source optical coherence tomography

      Postprocessing algorithms to minimize fixed-pattern artifact and reduce trigger jitter in swept source optical coherence tomography
      ...or Affiliations Gangjun Liu,^1,^* Ou Tan,^1 Simon S. Gao,^1 Alex D. Pechauer,^1 ByungKun Lee,^2 Chen D. Lu,^2 James G. Fujimoto,^2 and David Huang^1 ^1Casey Eye Institute, Oregon Health & Science University, Portland, ...
      Read Full Article
    4. Massachusetts Institute of Technology Received a 2015 NIH Grant for Novel Diagnostics with Optical Coherence Tomography

      Massachusetts Institute of Technology Received a 2015 NIH Grant for Novel Diagnostics with Optical Coherence Tomography
      ...eived a 2015 NIH Grant for Novel Diagnostics with Optical Coherence Tomography. The principal investigator is James Fujimoto. The program began in 1985 and ends in 2020. Below is a summary of the propose work. This prop...
      Read Full Article
    5. Post-doctoral Associate Position in Biophotonics / Biomedical Optical Imaging at Lehigh University

      Post-doctoral Associate Position in Biophotonics / Biomedical Optical Imaging at Lehigh University
      ...development of diffuse optical spectroscopy and imaging techniques. In August 2007, Dr. Zhou joined Professor James G. Fujimoto’s Laser Medicine and Medical Imaging Group at the Massachusetts Institute of Technology (MIT...
      Read Full Article
    6. In vivo microvascular imaging of human oral and nasal cavities using swept-source optical coherence tomography with a single forward/side viewing probe

      In vivo microvascular imaging of human oral and nasal cavities using swept-source optical coherence tomography with a single forward/side viewing probe
      ... Choi, Ruikang K. Wang Optical Coherence Tomography and Coherence Domain Optical Methods in Biomedicine XIX James G. Fujimoto; Joseph A. Izatt; Valery V. Tuchin San Francisco, California, United States | February 07, ...
      Read Full Article
    7. 1-15 of 319 1 2 3 4 ... 20 21 22 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About James G. Fujimoto

    James G. Fujimoto

    James. G. Fujimoto is a principal investigator in the Research Laboratory of Electronics (RLE) at the Massachusetts Institute of Technology (MIT). He received his S.B., S.M., and Ph.D. in electrical engineering from MIT in 1979, 1981, and 1984 respectively. He joined the MIT faculty in 1985 as Assistant Professor of Electrical Engineering. Since 1994, he has been Professor of Electrical Engineering at MIT and Adjunct Professor of Ophthalmology at Tufts University.

    Professor Fujimoto's area of research involves the development and application of femtosecond laser technology, studies of ultrafast phenomena, and laser medicine and surgery. His research group in RLE and collaborators invented optical coherence tomography and pioneered its development. 

    James G Fujimoto has published over 250 journal articles, is editor or author of 5 books, and holds numerous U.S. patents for his discoveries. He is a fellow of the National Academy of Engineering and the American Association for the Advancement of Science. Among his many honors include the 1999 Discover Magazine Award for Technological Innovation and the 2001 Rank Prize in Optoelectronics.

  3. Quotes

    1. The newest swept-source OCT has the advantage that the light source frequency sweep range and repetition rate can be adjusted to tailor the resolution, imaging range, and axial scan repetition rate for the specific imaging application.
      In Swept-source OCT and glaucoma
    2. We are now approaching a point with OCT where ophthalmologists have a view of the retina that is similar to that of pathologists...In the future, functional imaging will make subtle changes in pathology more measurable, and these advances will enhance sensitivity when monitoring disease progression and response to therapy.
      In How hardware, software advances expand OCT capabilities
    3. Hand-held instruments can enable screening a wider population outside the traditional points of care...The hand-held platform allows the diagnosis or screening to be performed in a much wider range of settings...Developing screening methods that are accessible to the larger population could significantly reduce unnecessary vision loss.
      In Early Detection of Blinding Eye Disease Could be as Easy as Scanning a Barcode
    4. Hand-held instruments can enable screening a wider population outside the traditional points of care.
      In Early Detection of Blinding Eye Disease Could be as Easy as Scanning a Barcode
    5. The hand-held platform allows the diagnosis or screening to be performed in a much wider range of settings.
      In Early Detection of Blinding Eye Disease Could be as Easy as Scanning a Barcode
    6. Partnership between academics and industry was critical for the development of OCT and is a powerful approach for translating new scientific discoveries into real world clinical practice...Clinical researchers on our team as well as other clinicians at leading international medical centers worked with the early OCT technology, exploring new clinical applications and blazing a trail that the broader clinical community could follow. This interdisciplinary approach was key to the success of this technology.
      In MIT Researchers Dr. James Fujimoto and Mr. Eric Swanson Awarded the 2012 António Champalimaud Vision Award
    7. OCT has the advantage that it can image 1 or 2 millimeters below the surface with high resolution, noninvasively...Increased imaging speed is important; it allows broader coverage or improved resolution...the concept is not that the technology is trying to diagnose the cancer per se, since excisional biopsies do that well...Instead, it is coupling 3D OCT scanning across the sampling area with standard biopsies.
      In Optical Tomography May Aid 3D Cancer Diagnostics
    8. Ultrahigh-speed imaging is important because it enables the acquisition of large three-dimensional volumetric data sets with micron-scale resolution.
      In New High-speed 3-D Imaging System Holds Potential for Improved Cancer Screening
    9. Excisional biopsy is one of the gold standards for the diagnosis of cancer, but is a sampling procedure. If the biopsy is taken in a normal region of tissue and misses the cancer, the biopsy result is negative although the patient still has cancer.
      In New High-speed 3-D Imaging System Holds Potential for Improved Cancer Screening
    10. This device development is one of the major technical challenges in endoscopic OCT because probes must be small enough so that they can be introduced into the body, but still be able to scan an optical beam at high speeds...Increasing imaging speeds has also been an important research objective because high-resolution volumetric imaging requires very large amounts of data in order to cover appreciable regions of tissue, so rapid image acquisition rates are a powerful advantage.
      In New High-speed 3-D Imaging System Holds Potential for Improved Cancer Screening